Nifty, Sensex at record highs buoyed by Covid vaccine progress


(MENAFN- Khaleej Times) Indian shares posted another record high on Wednesday as the world's second worst coronavirus-affected country considers approving vaccines for the public, raising bets of an economic recovery.

The country's federal health secretary said on Tuesday the country may approve some coronavirus vaccines over the next few weeks and an estimated 300 million people would be inoculated in the first tranche.

The NSE Nifty 50 index rose 0.51 per cent on Wednesday to 13,461.35 by 0345 GMT and was headed for a seventh consecutive session of gains, while the benchmark S&P BSE Sensex was up 0.52 per cent at 45,846.68. Both have hit record highs in 14 of the last 21 sessions.

India's largest listed company Reliance Industries Ltd boosted the indexes with a gain of 1.1 per cent. Consumer goods giant ITC Ltd led gains in percentage terms, rising 1.9 per cent to its highest since Aug. 11.

Britain on Tuesday started a mass Covid-19 vaccination campaign. Adding to market optimism, Johnson & Johnson said it could obtain late-stage trial results for a single-dose vaccine in January, earlier than expected.

MENAFN09122020000049011007ID1101255433


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.